Impact of Probiotics BIFILACT® on Diarrhea in Patients Treated With Pelvic Radiation
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
In this double-blinded randomized clinical trial study, investigators assessed probiotic used
to prevent or delay radiation induced grade moderate to severe diarrhea with patient treated
for pelvic cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Québec, CHU de Québec CHU de Quebec-Universite Laval